Global Cord Blood Corporation
Symboli: CO
NYSE
2.9876
USDMarkkinahinta tänään
5.2326
P/E-suhde
-0.0019
PEG-suhde
400.08M
MRK Cap
- 0.00%
DIV Tuotto
Global Cord Blood Corporation (CO) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 161.3 | 130.3 | 104.3 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 45.9 | 44.3 | 43.8 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 11.9 | 47.8 | 44.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 6935 | 6298.1 | 5666.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 476.7 | 503.7 | 527.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 60.8 | 55.8 | 50.7 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 696.2 | 653.4 | 592.5 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1599.5 | 1608.2 | 1553.7 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.3 | 9.5 | 20 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 1.6 | 1.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 31.2 | 29.5 | 32.3 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 1.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 2473.5 | 2392.9 | 2289.8 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 179.8 | 166 | 146.3 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 3003 | 2891.4 | 2760.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 3649.6 | 3517.9 | 3331.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 2887.3 | 2386.2 | 1877.9 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -106.8 | -103.2 | -94.7 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2098.8 | 2098.8 | 2098.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 4879.3 | 4381.9 | 3882.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 5.7 | 6.6 | 6.4 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 4885 | 4388.5 | 3888.5 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | -6660.8 | -6074 | -5469.9 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 509.5 | 516.2 | 477.7 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.1 | 49.4 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 3.2 | -7.2 | -7.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 11.7 | 37.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -3.8 | 58.3 | 64.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -102.9 | -120.4 | -86.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | -5.3 | -6.8 | -24.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -1.1 | -10.5 | -13.6 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 105.7 | 196.1 | 188.6 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 56.7 | 2.6 | 2.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -340 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 210 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.2 | 0.8 | 8.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -19.6 | -20.1 | -146.1 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.1 | -2.1 | 1.6 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.2 | 602.4 | 475.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 6075.8 | 5473.4 | 4997.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 613.6 | 630.7 | 624 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 593.8 | 609.8 | 599.8 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1243.3 | 1159.6 | 1221.5 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 183.3 | 178.9 | 189.1 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1059.9 | 980.7 | 1032.3 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 451.1 | 435.8 | 473.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 634.4 | 614.8 | 662.4 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 32.6 | 30.9 | 25.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.9 | -26.8 | 13 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | 608.9 | 544.9 | 559 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 627.8 | 610.8 | 578.8 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 118.4 | 94.5 | 101.1 | ||||||||||||||||
income-statement-row.row.net-income | 0 | 501.1 | 508.2 | 470.7 |
Usein kysytty kysymys
Mikä on Global Cord Blood Corporation (CO) taseen loppusumma?
Global Cord Blood Corporation (CO) kokonaisvarat ovat 8534525000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.853.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 4.885.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.403.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.490.
Mikä on Global Cord Blood Corporation (CO) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 501065000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 147000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 451083000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.